TOPICS

Category: Case Series

Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine

by Philip Milam, MD; Michael Berger, PharmD; Bhuvaneswari Ramaswamy, MD; Raquel Reinbolt, MD; Robert Wesolowski, MD; and Benjamin H. Kaffenberger, MD Drs. Milam and Kaffenberger are with the Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio. Drs. Berger, Ramaswamy, Reinbolt, and Weslowski are with the Division of Medical Oncology at The

CONTINUE READING »

Erbium-doped Yttrium Aluminium Garnet (Er:YAG) Laser Resurfacing Restores Normal Function and Cosmesis in Patients with Severe Rhinophyma

by Jason Mathis, MD; and Sherrif F. Ibrahim, MD, PhD Drs. Mathis and Ibrahim are with the Department of Dermatology at the University of Rochester Medical Center in Rochester, New York. FUNDING: No funding was provided for this study. DISCLOSURES: Dr. Ibrahim is a paid consultant and/or speaker for Sciton, Genentech and Regeneron. Dr. Mathis

CONTINUE READING »

Effective Treatment of Morbihan’s Disease with Long-term Isotretinoin: A Report of Three Cases

 J Clin Aesthet Dermatol. 2019;12(1):32–34 by Verónica Olvera-Cortés, MD, and Nancy Pulido-Díaz, MD Drs. Olvera-Cortés and Pulido-Díaz are with the Dermatology Department at the Mexican Institute of Social Security and National Medical Center La Raza in Mexico City, Mexico. Funding: No funding was received for this study. Disclosures: The authors have no conflicts of interest

CONTINUE READING »

Topical Growth Factors for the Treatment of Facial Photoaging: A Clinical Experience of Eight Cases

J Clin Aesthet Dermatol. 2018;11(12):28–29 by Ruri D. Pamela, MD Dr. Pamela is with the Department of Dermatology & Venereology at Dr. Suyoto Hospital in Jakarta, Indonesia. FUNDING: This study was funded by Highside Corp. in Tokyo, Japan. DISCLOSURES: Dr. Pamela is an employee of Highside Corp. Abstract: Background.Chronic exposure to solar ultraviolet irradiation can

CONTINUE READING »